These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31918023)

  • 1. A computational framework and sensitivity analysis for the hormonal treatment of bone.
    Idrees M; Sohail A
    Clin Biomech (Bristol, Avon); 2020 Mar; 73():9-16. PubMed ID: 31918023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone.
    Komarova SV
    Endocrinology; 2005 Aug; 146(8):3589-95. PubMed ID: 15860557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells.
    Florencio-Silva R; Sasso GR; Sasso-Cerri E; Simões MJ; Cerri PS
    Biomed Res Int; 2015; 2015():421746. PubMed ID: 26247020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of bisphosphonate treatment on the biochemical and cellular events during bone remodelling in response to microinjury stimulation.
    Mulcahy LE; Curtin CM; McCoy RJ; O'Brien FJ; Taylor D; Lee TC; Duffy GP
    Eur Cell Mater; 2015 Nov; 30():271-81. PubMed ID: 26614482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutical horizons in the management of postmenopausal osteoporosis.
    Migliaccio S; Fornari R; Greco EA; Di Luigi L; Lenzi A
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S117-9. PubMed ID: 24048905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Dimensional Co-Culture System of Human Osteoblasts and Osteoclast Precursors from Osteoporotic Patients as an Innovative Model to Study the Role of Nutrients: Focus on Vitamin K2.
    Mandatori D; Penolazzi L; Pelusi L; Lambertini E; Michelucci F; Porreca A; Cerritelli P; Pipino C; Di Iorio A; Bruni D; Di Nicola M; Buda R; Piva R; Pandolfi A
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone histology after intermittent PTH treatment - animal models -].
    Sasaki M; Hasegawa T; Hongo H; Yamamoto T; Amizuka N
    Clin Calcium; 2013 Mar; 23(3):347-53. PubMed ID: 23445886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling.
    Komarova SV; Smith RJ; Dixon SJ; Sims SM; Wahl LM
    Bone; 2003 Aug; 33(2):206-15. PubMed ID: 14499354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.
    Wang Y; Qin QH; Kalyanasundaram S
    Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone physiology and the osteoporotic process.
    Smith R
    Respir Med; 1993 Feb; 87 Suppl A():3-7. PubMed ID: 8497713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.
    Iolascon G; Resmini G; Tarantino U
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S19-22. PubMed ID: 24046050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the anabolic response of bone using a cell population model.
    Buenzli PR; Pivonka P; Gardiner BS; Smith DW
    J Theor Biol; 2012 Aug; 307():42-52. PubMed ID: 22579551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the bone anabolic agent by intravital imaging technique.].
    Morimoto A; Kikuta J; Furuya M; Ishii M
    Clin Calcium; 2018; 28(2):243-248. PubMed ID: 29371491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
    Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
    Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new biological bone remodeling in silico model combined with advanced discretization methods.
    Peyroteo MMA; Belinha J; Dinis LMJS; Natal Jorge RM
    Int J Numer Method Biomed Eng; 2019 Jun; 35(6):e3196. PubMed ID: 30835964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysics and the nonlinear dynamics instigated by a special hormone.
    Javed S; Sohail A; Asif A; Nutini A
    Prog Biophys Mol Biol; 2020 Jan; 150():62-66. PubMed ID: 31121190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
    Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
    Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous delivery of BMP-2 factor and anti-osteoporotic drugs using hyaluronan-assembled nanocomposite for synergistic regulation on the behaviors of osteoblasts and osteoclasts in vitro.
    Zhang Y; Hu Y; Luo Z; Shen X; Mu C; Cai K
    J Biomater Sci Polym Ed; 2015; 26(5):290-310. PubMed ID: 25585099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.